The movement toward measuring patient outcomes resulting from a specific drug therapy, especially in an environment increasingly focused on specialty medicines, has caused researchers to look at different datasets than previously analyzed. Two patient-based datasets in particular come to mind: 1.) electronic health records (EHR), and 2.) claims data. These two data sources will each be suited to answer different business questions.
The topics this white paper will review are which dataset is more appropriate for answering certain types of business questions, look at some cases from the academic literature that apply each dataset, and state implications these datasets have for the development and execution of future biopharma commercial analytics.
Contact us at insights@axtria.com with any questions.